Ivim Health's GLP-1 ID program primarily uses compounded semaglutide and compounded tirzepatide
1 Initial three-month interim data from this first-of-its-kind trial suggest that this treatment combination effectively improved facial aesthetic appearance with high patient satisfaction
Cure rates of 86% to 95% have been reported for radiation therapy with Grenz rays or superficial x-rays using the Miescher technique, but they are from small series with short follow-up times (2-5 years)2 (Table 6)
The GLP-1 universe instead is a diverse array that includes long-term users, users that go on and off, former users who permanently changed how they eat, people using supplements or compounds, and even people who just live in a household with a GLP-1 user and buy different groceries as a result
In the novelty suppressed feeding test, PE-22-28 reduced latency to feed, an effect that requires chronic antidepressant treatment with SSRIs but occurred after acute PE-22-28 administration
Peptide Manufacturing: Commercial scale block ready for validation during Q2 FY27
)
